Robotic-assisted coronary angioplasty procedures will be highlighted during CRT 2014


Corindus Vascular Robotics announced that in addition to a talk focusing on robotics in the future of the cath lab, cases submitted by users of its CorPath Vascular Robotics system have been accepted for presentation at the Cardiovascular Research Technologies (CRT) conference on February 22 – 25, 2014 in Washington, DC, USA.

According to a press release, the CorPath system is the first and only Food and Drug Administration-cleared technology that enables precise, robotic-assisted angioplasties to open arteries and restore blood flow in patients with coronary artery disease. Giora Weisz, chairman of Cardiology at Shaare Zedek Medical Centre in Israel will discuss how this technology will fit into the “Cath Lab of the Future” while the cases accepted to the CRT conference discuss the current clinical use of CorPath.


Puneet Sharma, interventional cardiologist at Sanford Clinic in Aberdeen, USA, had a case selected as an Interesting Case for the conference. Sharma’s case submission details the first robotic-assisted stent placement in acute heart-attack within the 90 minute door to balloon guideline.

“Our facility became the first hospital to perform a robotic angioplasty for a patient with an acute heart attack well within the national guidelines of 90 minutes,” notes Sharma. “Using the CorPath System, I was able to restore blood flow to the patient’s heart within 68 minutes of his arrival.”

The CorPath System enables precisely controlled, robotic-assisted angioplasties while the physician is seated in a lead-lined interventional cockpit protected from radiation exposure. CorPath enables the cardiologist to advance stents and guidewires millimetre-by-millimetre via a joystick.


“Having performed more than 30 robotic-assisted angioplasties using the CorPath System, it is clear that this technology has set a new standard in vascular procedures,” says Ronald Caputo, director of Cardiac Services and Cardiology Research at St. Joseph’s Hospital in Syracuse, USA. “We continue to take advantage of CorPath’s measurement tools, improved control and visualisation enabling the interventional cardiologist to provide the ultimate quality of care that we strive to deliver to patients.”